Header cover image

Retail Healthcare Sector

Results

2309

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2,309 companies

Vaccinex

Market Cap: US$2.8m

A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.

VCNX

US$1.04

7D

52.9%

1Y

-81.2%

Itoco

Market Cap: US$2.8m

Engages in the processing, production, and distribution of medical cannabis products.

ITMC

US$0.0065

7D

0%

1Y

30.0%

Nuformix

Market Cap: UK£2.1m

Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.

NFX

UK£0.0013

7D

-3.8%

1Y

-32.4%

Revelation Biosciences

Market Cap: US$2.8m

Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.

REVB

US$3.05

7D

-4.0%

1Y

-90.6%

Spruce Biosciences

Market Cap: US$2.7m

A biopharmaceutical company, focuses on developing and commercializing novel therapies for neurological disorders.

SPRB

US$0.065

7D

-13.0%

1Y

-91.3%

Awakn Life Sciences

Market Cap: CA$4.0m

A biotechnology company, engages in the research, development, operation, and delivery of psychedelic therapeutics to treat addiction and other mental health conditions in North America and Europe.

AWKN

CA$0.095

7D

0%

1Y

-26.9%

Akanda

Market Cap: US$2.7m

Through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products for medicinal use worldwide.

AKAN

US$1.20

7D

3.4%

1Y

-91.3%

Marvel Biosciences

Market Cap: CA$3.8m

A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.

MRVL

CA$0.085

7D

-5.6%

1Y

-5.6%

Scinai Immunotherapeutics

Market Cap: US$2.7m

A development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel.

SCNI

US$2.91

7D

12.8%

1Y

-35.3%

Xebra Brands

Market Cap: CA$3.8m

Engages in the cultivation, processing, manufacture, design, and delivery of cannabis products in Canada, Europe, and Mexico.

XBRA

CA$0.045

7D

12.5%

1Y

-55.0%

IQ-AI

Market Cap: UK£2.0m

Through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States.

IQAI

UK£0.0083

7D

-2.9%

1Y

-44.3%

Catheter Precision

Market Cap: US$2.7m

Designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States.

VTAK

US$0.29

7D

1.4%

1Y

-95.0%

Galmed Pharmaceuticals

Market Cap: US$2.7m

A biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases.

GLMD

US$1.19

7D

-4.0%

1Y

-75.5%

QHSLab

Market Cap: US$2.7m

A medical device technology and software-as-a-service SaaS company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine including digital therapeutics.

USAQ

US$0.24

7D

39.9%

1Y

101.3%

Theriva Biologics

Market Cap: US$2.7m

A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.

TOVX

US$0.56

7D

5.5%

1Y

-94.0%

Tivic Health Systems

Market Cap: US$2.6m

Operates as a health tech company, develops and commercializes bioelectronic medicine.

TIVC

US$4.27

7D

8.4%

1Y

-46.7%

Patrys

Market Cap: AU$4.1m

Develops and commercializes antibody technologies for the treatment of cancer in Australia.

PAB

AU$0.002

7D

-33.3%

1Y

-73.3%

NLS Pharmaceutics

Market Cap: US$2.6m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders.

NLSP

US$1.62

7D

-1.5%

1Y

-75.4%

ValiRx

Market Cap: UK£2.0m

A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.

VAL

UK£0.0053

7D

-4.5%

1Y

-76.1%

Appili Therapeutics

Market Cap: CA$3.6m

A biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada.

APLI

CA$0.03

7D

0%

1Y

-14.3%

Escalon Medical

Market Cap: US$2.6m

Engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally.

ESMC

US$0.35

7D

88.5%

1Y

74.4%

AVVAA World Health Care Products

Market Cap: US$2.6m

Provides natural and therapeutic skin care products worldwide.

AVVH

US$0.0027

7D

0.8%

1Y

97.8%

Talis Biomedical

Market Cap: US$2.6m

Operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States.

TLIS

US$1.41

7D

-11.9%

1Y

-84.3%

Biotron

Market Cap: AU$4.0m

A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.

BIT

AU$0.003

7D

0%

1Y

-94.5%

Ridder Titan Genesis

Market Cap: US$2.5m

A medical marijuana company, focuses on the development of whole plant extractions for the cancer and palliative treatments.

RTGC

US$0.38

7D

52.0%

1Y

-20.8%

Freedom Care Group Holdings

Market Cap: AU$4.0m

Provides care and support services to individuals with disabilities in Australia.

FCG

AU$0.037

7D

0%

1Y

-76.9%

Psykey

Market Cap: US$2.5m

Engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life.

CEOS

US$0.0075

7D

-30.0%

1Y

-52.5%

Intelicare Holdings

Market Cap: AU$3.9m

Engages in the research, development, and sale of predictive analytics hardware and software package for use in the aged care, disability, and health industries in Australia.

ICR

AU$0.008

7D

0%

1Y

-27.3%

Alzamend Neuro

Market Cap: US$2.5m

A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.

ALZN

US$3.40

7D

-42.6%

1Y

-94.0%

Megola

Market Cap: US$2.5m

Develops and sells various physical water treatment devices.

MGON

US$0.0085

7D

0%

1Y

23.2%

Can B

Market Cap: US$2.5m

Develops, manufactures, and sells hemp biomass derived products containing cannabinoids.

CANB

US$0.028

7D

-23.4%

1Y

19.6%

Stem Cell Authority

Market Cap: US$2.4m

A technology development company, focuses on the collection and cryogenic preservation of stem cells.

SCAL

US$0.0002

7D

0%

1Y

-93.8%

THC Biomed Intl

Market Cap: CA$3.3m

Produces and sells medical and recreational cannabis in Canada.

THC

CA$0.02

7D

0%

1Y

-50.0%

AXIM Biotechnologies

Market Cap: US$2.4m

Engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases.

AXIM

US$0.0072

7D

-7.7%

1Y

-28.5%

Bone Biologics

Market Cap: US$2.4m

A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.

BBLG

US$0.72

7D

-3.8%

1Y

-61.6%

One World Products

Market Cap: US$2.3m

One World Products, Inc. intends to produce raw cannabis and hemp plant ingredients for medical and industrial uses.

OWPC

US$0.022

7D

5.2%

1Y

-62.2%

Page 46 of 65